Role of anlotinib plus albumin paclitaxel regimen in stage IV non-small cell lung cancer and mental state

doi:10.5498/wjp.v15.i8.103735

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 8

This Article

(52)

(56)

(0)

(1308)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Psychiatry

ISSN

2220-3206

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Psychiatry. Aug 19, 2025; 15(8): 103735
Published online Aug 19, 2025. doi: 10.5498/wjp.v15.i8.103735

Full Size Figure Download Figure

Figure 2 Comparison of progression-free survival and overall survival. A: Progression-free survival; B: Overall survival. PFS: Progression-free survival; OS: Overall survival. ^aP < 0.05 vs conventional therapy.

Citation: Zhang W, Zhao YF, Liang FF, Liu XX, Liu JH, Hao JD, Cheng SQ, Wu YF. Role of anlotinib plus albumin paclitaxel regimen in stage IV non-small cell lung cancer and mental state. World J Psychiatry 2025; 15(8): 103735
URL: https://www.wjgnet.com/2220-3206/full/v15/i8/103735.htm
DOI: https://dx.doi.org/10.5498/wjp.v15.i8.103735

Zhang W, Zhao YF, Liang FF, Liu XX, Liu JH, Hao JD, Cheng SQ, Wu YF. Role of anlotinib plus albumin paclitaxel regimen in stage IV non-small cell lung cancer and mental state. World J Psychiatry 2025; 15(8): 103735 [PMID: 40837809 DOI: 10.5498/wjp.v15.i8.103735]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.